Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian Goodell

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Psychopharmacology|May 25, 2011
Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individualsAmanda E Higley, Natania A Crane, Andrea D Spadoni, et al.
Clinical Immunology (Orlando, Fla.)|October 5, 2007
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancersLupe G Salazar, Andrew L Coveler, Ron E Swensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo primingYushe Dang, Keith L Knutson, Vivian Goodell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancerVivian Goodell, Lupe G Salazar, Nicole Urban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccineMary L Disis, Kathy Schiffman, Katherine Guthrie, et al.
Breast Cancer Research and Treatment|February 1, 2008
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunityAndrew L Coveler, Vivian Goodell, Devon J Webster, et al.
Cancer Research|October 17, 2008
Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancerKyong Hwa Park, Ekram Gad, Vivian Goodell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2012
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adultsBarbara J Mason, Rebecca Crean, Vivian Goodell, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 21, 2012
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer seraHailing Lu, Jon Ladd, Ziding Feng, et al.
Molecular Cancer Therapeutics|March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunityVivian Goodell, James Waisman, Lupe G Salazar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Psychopharmacology|May 25, 2011
Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individualsAmanda E Higley, Natania A Crane, Andrea D Spadoni, et al.
Clinical Immunology (Orlando, Fla.)|October 5, 2007
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancersLupe G Salazar, Andrew L Coveler, Ron E Swensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo primingYushe Dang, Keith L Knutson, Vivian Goodell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancerVivian Goodell, Lupe G Salazar, Nicole Urban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccineMary L Disis, Kathy Schiffman, Katherine Guthrie, et al.
Breast Cancer Research and Treatment|February 1, 2008
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunityAndrew L Coveler, Vivian Goodell, Devon J Webster, et al.
Cancer Research|October 17, 2008
Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancerKyong Hwa Park, Ekram Gad, Vivian Goodell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2012
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adultsBarbara J Mason, Rebecca Crean, Vivian Goodell, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 21, 2012
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer seraHailing Lu, Jon Ladd, Ziding Feng, et al.
Molecular Cancer Therapeutics|March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunityVivian Goodell, James Waisman, Lupe G Salazar, et al.
Pageof 3